Log In
Print
BCIQ
Print
Print this Print this
 

AZD5363

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionProtein kinase B (PKB; PKBA; AKT; AKT1) inhibitor
Molecular Target Protein kinase B (PKB) (PKBA) (AKT) (AKT1)
Mechanism of ActionProtein kinase B (PKB) (AKT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors; Treat solid tumors
Regulatory Designation

Partner

AstraZeneca plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today